Page last updated: 2024-08-23

paclitaxel and Blood Loss, Surgical

paclitaxel has been researched along with Blood Loss, Surgical in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bassett, R; Coleman, RL; Dos Reis, R; Harrell, R; Milam, MR; Ramirez, PT; Tao, X	1
Blum, MG; Boggio, LN; Laselle, BT	1

Other Studies

2 other study(ies) available for paclitaxel and Blood Loss, Surgical

Article	Year
Neoadjuvant chemotherapy is associated with prolonged primary treatment intervals in patients with advanced epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Surgical; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Disease-Free Survival; Female; Humans; Hysterectomy; Kaplan-Meier Estimate; Length of Stay; Middle Aged; Neoadjuvant Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Statistics, Nonparametric; Survival Analysis; Time Factors; Treatment Outcome; Young Adult	2011
Presentation and management of a stage Ia lung cancer patient with a paraneoplastic factor VIII inhibitor. The Annals of thoracic surgery, 2006, Volume: 81, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Autoimmune Diseases; Blood Coagulation Factors; Blood Loss, Surgical; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Diabetes Mellitus, Type 2; Factor VIII; Hemorrhage; Humans; Hyperglycemia; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Neoplasms; Male; Neoplasm Staging; Paclitaxel; Paraneoplastic Syndromes; Partial Thromboplastin Time; Pneumonectomy; Prednisone	2006

Article

Year

Neoadjuvant chemotherapy is associated with prolonged primary treatment intervals in patients with advanced epithelial ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Surgical; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Disease-Free Survival; Female; Humans; Hysterectomy; Kaplan-Meier Estimate; Length of Stay; Middle Aged; Neoadjuvant Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Statistics, Nonparametric; Survival Analysis; Time Factors; Treatment Outcome; Young Adult

2011

Presentation and management of a stage Ia lung cancer patient with a paraneoplastic factor VIII inhibitor.

The Annals of thoracic surgery, 2006, Volume: 81, Issue:1

Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Autoimmune Diseases; Blood Coagulation Factors; Blood Loss, Surgical; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Diabetes Mellitus, Type 2; Factor VIII; Hemorrhage; Humans; Hyperglycemia; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Neoplasms; Male; Neoplasm Staging; Paclitaxel; Paraneoplastic Syndromes; Partial Thromboplastin Time; Pneumonectomy; Prednisone

2006